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Abstract
Background:  In routine Assisted Reproductive Technology (ART) men with severe
oligozoospermia or azoospermia should be informed about the risk of de novo congenital or
chromosomal abnormalities in ICSI program. Also the benefits of preimplantation or prenatal
genetic diagnosis practice need to be explained to the couple.
Methods:  From a routine ICSI attempt, using ejaculated sperm from male with severe
oligozoospermia and having normal karyotype, a 30 years old pregnant woman was referred to
prenatal diagnosis in the 17th week for bichorionic biamniotic twin gestation. Amniocentesis was
performed because of the detection of an increased foetal nuchal translucency for one of the fetus
by the sonographic examination during the 12th week of gestation (WG). Chromosome and DNA
studies of the fetus were realized on cultured amniocytes
Results: Conventional, molecular cytogenetic and microarray CGH experiments allowed us to
conclude that the fetus had a de novo pericentromeric inversion associated with a duplication of the
9p22.1-p24 chromosomal region, 46,XY,invdup(9)(p22.1p24) [arrCGH 9p22.1p24 (RP11-130C19
→ RP11-87O1)x3]. As containing the critical 9p22 region, our case is in coincidence with the
general phenotype features of the partial trisomy 9p syndrome with major growth retardation,
microcephaly and microretrognathia.
Conclusion: This de novo complex chromosome rearrangement illustrates the possible risk of
chromosome or gene defects in ICSI program and the contribution of array-CGH for mapping
rapidly de novo chromosomal imbalance.
Background
In Assisted reproductive technology (ART), male with
severe oligozoospermia or azoospermia should be offered
genetic/clinical counselling for informed consent about
the risk of de novo congenital or chromosomal abnormal-
ities before ICSI [1]. The precise risks of genes imprinting
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and childhood cancer from ART is still unclear but can not
be ignored [2]. Furthermore, gene expression and methyl-
ation status in animal embryos can be affected by chang-
ing the culture conditions during ART processes [3].
Partial trisomy 9p is a frequently described chromosome
abnormality. The partial trisomic fragments of the pub-
lished cases are heterogeneous causing unusual presenta-
tions of characterized phenotypes [4-6]. The cases with
such abnormalities usually present considerable diagnos-
tic difficulties both clinically and cytogenetically.
In clinical cytogenetics, the precise identification of the
chromosomal abnormality is a key factor when consider-
ing genotype-phenotype correlation. Advances in molecu-
lar cytogenetics have allowed more precise analysis of
complex chromosomal rearrangements, especially with
FISH techniques, spectral karyotyping and conventional
CGH. The developments of the array-CGH the accuracy of
identification of complex chromosomal anomalies, such
as unbalanced intrachromosomal rearrangements [7,8].
Microarray CGH technology was recently applied to con-
stitutional chromosomal abnormalities demonstrating its
sensitivity parallelly with the use of other techniques to
detect submicroscopic chromosomal aberrations [9-13].
This technology can therefore be applied in prenatal diag-
nosis to reveal, with a higher resolution, chromosomal
imbalances in malformed foetuses [14]. For molecular
karyotyping Array CGH (A-CGH) methods are superior to
FISH in not requiring suitable nuclear preparations and in
not being limited to probes used. They are also superior to
routine metaphase CGH because of their higher resolu-
tion, easier interpretation and hold the promise and rou-
tine diagnostic tool to identify visible and submicroscopic
chromosome abnormalities [12,15,16].
From a routine ICSI attempt, using ejaculated sperm from
male with severe oligozoospermia and having normal
karyotype, we report the first prenatal diagnosis of a de
novo pericentric inversion and duplication of a large seg-
ment of the short arm of a chromosome 9, characterized
by CGH array and FISH. Risks of de novo chromosomal
and genetics disorders after ART are discussed.
Methods
Case report
Intra Cytoplasmic Sperm Injection was applied for oligoa-
zoospermia indication. Three embryos were transferred at
day 3. The transfer led to twin pregnancies. Amniocentesis
was performed because of the detection of an increased
foetal nuchal translucency for one of the fetus by the
sonographic examination during the 12th week of gesta-
tion (WG). The parents were both healthy, non-consan-
guineous. There was no family history of genetic or
congenital disorders. The couple had a spontaneous abor-
tion at 24th WG, without any diagnosis found (normal
autopsy and normal foetal karyotype). Ultrasound exam-
ination at 21th WG revealed for this fetus, brachycephaly,
short femur, intra uterine growth retardation (<3rd percen-
tile), little low set ears, little stomach and increased amni-
otic fluid volume. The foetal karyotype showed a de novo
abnormal chromosome 9. The parents were informed
about the poor prognosis of this fetus. After interdiscipli-
nary discussion, selective termination of pregnancy was
performed at 34th WG according to French law. The nor-
mal twin was eutrophic with a normal clinical examina-
tion. The abnormal fetus was referred to the department
of foetal pathology. Anatomic examination showed
microcephaly and dysmorphic features such as low set,
malformed protruding asymmetric ears, short philtrum,
and microretrognathia, contracted hands with hypoplasia
of the medium phalange of the fifth fingers, left foot in
varus, hypertelorism, mild bilateral urethral dilatation
and major growth retardation (fig. 1).
Cytogenetic investigations
Amniocytes were cultured using standard in situ tech-
nique. Peripheral blood samples of both of the parents
and of the fetus were stimulated with PHA and cultured
72 hours before harvesting. Foetal skin sample was treated
and cultured using standard protocols. Chromosome
studies of the fetus were realized on cultured amniocytes
and cultured skin samples using G-banding, R-banding
and C-banding techniques performed according to the
standard procedure. The chromosomes from peripheral
blood samples of the parents were analysed from cultured
lymphocytes.
Array CGH – DNA microarray analysis
We used human genomic micro arrays containing 2600
BAC/PAC clones with an average of 1 MB resolution along
the human genome (Human BAC Array-1 MB system,
Spectral Genomics Inc., Houston, Texas, USA). This micro
array includes subtelomeric regions as well as critical areas
spaced roughly 1 Mb along each of the human autosomes
as well as the X and Y chromosomes. Data on the DNA
clones are available in the public records including their
map positions as identified by FISH and/or other tech-
niques http://www.ncbi.nlm.nih.gov/genome/cyto/
hbrc.shtml.
Total genomic DNA was obtained from cultured amnio-
cytes by a standard extraction using phenol/chloroform.
Test and control DNA samples (2 μg each) were digested
overnight with 80 units of EcoRI at 37°C and then puri-
fied by Zymo Research's column (Orange, CA, USA). The
test and reference DNAs were labelled with Cy3 and Cy5
using random prime labelling kit (Invitrogen, France) to
obtain a major labelled probe size between 100 to 500 bp.Molecular Cytogenetics 2008, 1:27 http://www.molecularcytogenetics.org/content/1/1/27
Page 3 of 10
(page number not for citation purposes)
Phenotype of the fetus Figure 1
Phenotype of the fetus. A) Face with hypertelorism, B) general view of the fetus showing microcephaly and contracted 
hands, C) profile showing microretrognathia and short upper philtrum, D) low-set asymetric malformed protruding ears.Molecular Cytogenetics 2008, 1:27 http://www.molecularcytogenetics.org/content/1/1/27
Page 4 of 10
(page number not for citation purposes)
For the hybridisation solution, Cy5 labelled Test DNA and
Cy3 labelled reference DNA samples were mixed with 65
ug of Cot-1 DNA and 35 μg of shared salmon testes DNA
then the mix was precipitated and washed with ethanol.
The same experiment was repeated with Cy3 labelled test
and Cy5 labelled reference test. This forward and reverse
hybridization switching of dyes helps address issues
related to dye specificity and strength. The pellets were
dissolved homogeneously in 10 μl of distilled water and
mixed with 50 μl of hybridisation solution (50% forma-
mide, 10% dextran sulphate in 2 × SSC). The hybridisa-
tion mix was denatured at 73° for 12 min and followed by
40 min at 37°C for annealing.
The forward and reverse hybridization reactions were
added on duplicate micro array slides and placed at 37°C
for 16 hrs. After hybridization, slides were washed briefly
at room temperature in 2 × SSC/0.5% SDS to remove the
hybridization solution, then 20 min in 2 × SSC/50%
deionised formamide at 50°C with shaking. The washing
steps were repeated at 50°C with shaking in 0.2 × SSC/
0.1% NP40 for 20 min and 0.2 × SSC for 20 min. Finally
the slides were rinsed briefly with distilled water at room
temperature and centrifuged for 3 min at 500 g for com-
plete drying.
Hybridized micro arrays were analysed with GenePix
4000B scanner (Axon Instruments Inc., Union City, CA,
USA). Cy3 and Cy5 images were scanned separately
through two different channels. Two 16 bit TIFF images
were created per array. Then the obtained data were ana-
lysed by Spectralware 1.0 software (Spectral Genomics
Inc., Houston, Texas, USA). The software recognizes the
regions of fluorescent signal determine signal intensity
and compile the data into a spreadsheet that link the flu-
orescent signal of every clone on the array to the clone
name, its duplicate position on the array and its position
in the genome. The software was also used to normalise
the Cy5:Cy3 intensity ratios for each slide and each data
point. Slide was normalised such that the summed Cy5
signal equal the summed Cy3 signal. The normalised
Cy3:Cy5 intensity ratios were computed for each two
slides and plotted together for each chromosome. The lin-
ear order of the clones is reconstituted in the ratio plots
consistent with an ideogram, such that the p terminus is
to the left and the q terminus is to the right of the plot.
Chromosomal areas are interpreted as overrepresented
when the ratio exceeds 1.2 which shows DNA copy
number gains or 1.5 which shows DNA copy number
amplifications with the blue ratio plot showing a positive
deviation (upward) and red ratio plot showing a negative
deviation (downward), reversely 0.8 and 0.5 for DNA
copy number losses or deletions respectively with the blue
ratio plot showing a negative deviation and red ratio plot
showing a positive deviation. On the ratio plots only the
deviations representing a mirror effect considered as sig-
nificant due to reverse and forward hybridization switch-
ing assays. As CGH recognizes only proportional changes
in copy number, the ratio profiles do not indicate the
absolute copy number changes. A ratio of 1.5 indicates at
least a 100% increase in the copy number of an entire
chromosome arm or of a region of a chromosome the size
of a chromosome band (e.g. chromosomal trisomy).
When a DNA copy number increase is restricted to a small
chromosome area representing, for example, amplifica-
tion of a single gene, then the copy number increase has
to be at least 1 Mb which is the resolution of the micro
array used.
Fluorescence in Situ Hybridisation (FISH)
FISH analyses were performed on metaphase spreads
from both cultured fetal skin and fetal blood with, whole
chromosome painting probe specific for chromosome 9
(Vysis, Rungis, France), partial chromosome painting
(PCP) probes specific for 9p and 9q arms (Cytocell,
Compiegne, France) and BAC/PAC clones specific for the
9p and 9q chromosomal regions. The satellite I (Cytocell)
and satellite III probes (Appligen Oncor, Illkirch, France)
specific for chromosome 9 were also used. The BAC DNAs
were labelled by nick-translation using a FITC-dUTP
nucleotide or a Rhodamine-dUTP nucleotide (Roche
Diagnostics, Meylan, France). Results were analyzed using
a Zeiss Axioplane microscope connected to a Photomet-
rics CCD camera and evaluated with the aid of IPLab-
Spectrum 3.0 software (Carl Zeiss S.A.S., France).
Results
Conventional cytogenetic analysis
Cytogenetic analysis of amniocytes revealed a 46,XY,9p+
karyotype for the abnormal fetus. R- and G-banding
results showed the presence of excedent material in the
short arm of one chromosome 9. C-banding showed the
presence of heterochromatin into the short arm of the
derivative chromosome 9 (fig. 2). Analysis of peripheral
blood lymphocytes of the parents showed normal karyo-
types.
Array CGH – DNA microarray analysis
The array-CGH profile for chromosome 9 showed a gain
between the chromosomal bands 9p24 and 9p22.1 (fig.
3). There were no copy number changes on the rest of the
genome of the fetus.
FISH analysis
FISH results with a whole-chromosome 9 painting probe
had shown rearranged chromosome 9 being entirely
hybridised and that there were no other chromosomes
implied in the chromosomal rearrangement. The PCP
(partial chromosome painting) probe specific for theMolecular Cytogenetics 2008, 1:27 http://www.molecularcytogenetics.org/content/1/1/27
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short arm of the chromosome 9 showed two hybridiza-
tion areas on the short arm and on the long arm of the
derivative chromosome 9 (fig. 4A). The PCP probe spe-
cific for the long arm of the chromosome 9 showed two
hybridization areas on the short arm and on the long arm
of the derivative chromosome 9.
Specific probe for the centromere of the chromosome 9
(satellite I) showed normal hybridization signals on both
normal and abnormal chromosomes 9. The probe specific
for the heterochromatin of the chromosome 9q (satellite
III) showed a splitted hybridization signal on the abnor-
mal chromosome 9. FISH results showed an inverted
duplication of the 9p22.1-9p24 chromosomal region (fig-
ure 4B). The results of the FISH experiments are presented
in table 1.
In summary, conventional and molecular cytogenetic
experiments allowed us to conclude that the fetus had a de
novo pericentromeric inversion associated with a duplica-
tion of the 9p22.1-p24 chromosomal region,
46,XY,invdup(9)(p22.1p24) [arrCGH 9p22.1p24 (RP11-
130C19 → RP11-87O1)x3].
Discussion
Men with severe oligozoospermia or azoospermia should
be offered genetic/clinical counselling for informed con-
sent about the risk of de novo congenital or chromosomal
abnormalities and somatic karyotyping before ICSI [1].
Jozwiak et al [17] showed that ICSI babies carry a signifi-
cant increase risk of an abnormal karyotype compared to
the children's conceived by natural pregnancies. However
this increase risk is similar among the different infertility
group. In early abortion before 12 weeks of pregnancies
conceived by IVF, the de novo chromosome aneuploidy is
a major factor affecting normal embryonic development
[18]. The precise risks of genes imprinting and childhood
cancer from ART is still unclear but can not be ignored [2].
From 23 women who had conceived by IVF and had abor-
tion before 12 weeks, Philipp et al [18] reported 17 of 23
specimens (73.9%) with chromosome abnormalities
using classical cytogenetics chorionic villi investigation.
The majority of observed chromosome abnormalities
were numerical such as monosomy and trisomies (includ-
ing 1 trisomy 9) with only one case of structural aberra-
tion leading to a trisomy.
Most of the genetic risk in ICSI is linked to the higher fre-
quency of chromosomal abnormalities in men with
severe oligoasthenoteratozoospermia or azoospermia,
genetic screening and counselling should be given before
ICSI [19]. Most studies of children conceived in vitro have
shown a negligible or only a slight excess risk of major and
minor birth defects [20,21]. However, the possibility of
those chromosomal abnormalities after ICSI may also be
due to disorders of mainly epigenetic origin since the
imprinting of genes plays an important role during preim-
plantation embryo development [22]. Furthermore, gene
expression and methylation status in animal embryos can
Conventional cytogenetic analysis results of the fetus Figure 2
Conventional cytogenetic analysis results of the fetus. G and R-banding results showing the addition of chromosomal 
materiel in the short arm of one chromosome 9 (der(9)). C-banding results showing an presence of heterochromatin into the 
der(9).Molecular Cytogenetics 2008, 1:27 http://www.molecularcytogenetics.org/content/1/1/27
Page 6 of 10
(page number not for citation purposes)
be affected by changing the culture conditions during ART
processes [3]. Nevertheless, there are no any imprinted
genes known on chromosome 9p according to the
Imprinted Gene Catalogue http://www.otago.ac.nz/IGC.
In the literature, no any data presented about de novo 9p
chromosomal arm rearrangements in ICSI conceptions,
which is the case in our study. In the literature there are a
few data concerning prenatal chromosome analysis after
ICSI. Bonduelle et al. [20] report that different structural
anomalies are found in 8 cases from 1437 (0.5%) abnor-
mal fetal karyotypes in prenatally tested ICSI fetuses [20].
The cytogenetic analysis of 475 fetus conceived by ICSI
showed 4.42% of chromosome abnormalities including
1.83% of structural aberrations [23]. This rate of de novo
Profile of chromosome 9 using a human 1 Mb genomic micro array showing a gain of the 9p24-p22.1 region Figure 3
Profile of chromosome 9 using a human 1 Mb genomic micro array showing a gain of the 9p24-p22.1 region.Molecular Cytogenetics 2008, 1:27 http://www.molecularcytogenetics.org/content/1/1/27
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abnormalities is nearly 2 fold higher than the percentage
reported by Bonduelle et al [20]. At present, we cannot
draw any significant conclusions from present data about
the influence of ICSI in producing chromosomal abnor-
malities. Moreover, a germinal mosaic in the father can-
not be excluded in this case but unfortunately sperm
analysis was not available to perform this research. This
uncertainty surely justifies the need for studying human
embryos and the survey of this work requiring a large
international effort. This research must be continued to
properly address the issue of safety of ICSI.
Partial trisomy 9p has been reported in few cases and
more frequently as a result of different types of transloca-
tions either de novo or inherited [24-29]. The prognosis of
partial trisomy 9p remains very pejorative and the termi-
nation of pregnancy is the most often proposed solution
[24]. Partial trisomy 9p is characterized by microcephaly
with large anterior fontanel and micrognathia, mal-
formed protruding ears, small sunken eyes, acentric dis-
placement of pupils, hypertelorism, enophthalmos,
downslanting palpebral fissures, large bulbous nose, short
philtrum, down-curved corners of the mouth, short or
webbed neck, small hands, clinodactyly, hypoplasia of the
phalanges, short and triangular distal phalanges of the
thumbs, spinal lordosis and scoliosis, delayed skeletal
maturation, congenital heart defects, kidney abnormali-
ties, mental retardation and frequent perinatal mortality.
Our case is in coincidence with the general phenotype fea-
tures of the trisomy partial 9p syndrome with major
growth retardation, microcephaly, microretrognathia, lit-
tle low set and malformed protruding ears, short
philtrum, hypertelorism and hypoplasia of the phalanges.
Up to now, prenatal diagnosis of partial trisomy 9p has
been described in 6 cases [24,30-33]. Ultrasound signs
reported in these cases were intrauterine growth retarda-
tion (2/6), cerebral anomalies (4/6), brachycephaly (1/6).
Nevertheless, this phenotypic variability can be explained
by the fact that the partial trisomy 9p was also associated
with another chromosomal anomaly in 5 of these 6 pub-
lished cases. Moreover, the sizes of partial trisomic 9p
fragments in these prenatal cases are also heterogeneous
participating to the phenotypic variability [4]. Previously
reports suggest that 9p22 may be responsible for the
observed phenotype in 9p duplication cases [34-36] have
suggested that the 9p duplication critical region lies
within a 6-Mb portion of 9p22 [36]. In our case, the dupli-
cated chromosomal region includes the 9p22 band. To
our knowledge, our case is the first report of a fetus with a
partial trisomy 9p associated with a pericentric inversion.
FISH results showing an inversion and duplication of the chromosomal region 9p24 and 9p22.1 Figure 4
FISH results showing an inversion and duplication of the chromosomal region 9p24 and 9p22.1. A) FISH with 
painting probe specific for 9p arm (red). B) FISH with RP11-39K24 BAC clone (green) corresponding to 9p24.1 and RP11-
149I2 BAC clone (red) corresponding to 9p21.3.Molecular Cytogenetics 2008, 1:27 http://www.molecularcytogenetics.org/content/1/1/27
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Advances in molecular cytogenetics have allowed more
precise analysis of complex chromosomal rearrange-
ments, especially with FISH techniques, spectral karyotyp-
ing and conventional CGH. The publication of the draft
sequence of human genome and recent development of
the array-CGH dramatically increased the accuracy of
identification of complex chromosomal anomalies, such
as intrachromosomal rearrangements.
Array comparative genome hybridization (Array CGH)
using spotted bacterial artificial chromosomes (BACs),
phage artificial chromosomes (PACs), cDNAs or oligonu-
cleotides was developed to detect chromosomal copy
number changes on a genome-wide and/or high resolu-
tion scale [37,38]. Array CGH has the potential to be
applied in clinical diagnostics and may address many of
the limitations of both conventional cytogenetics, FISH or
PCR [39]. CGH array limitations in a clinical cytogenetics
include its inability to detect polyploidy or balanced chro-
mosome abnormalities. Polyploidy can be easily detected
by FISH, micro satellite analysis, or flow cytometry. Bal-
anced translocations will still be detected using classic
cytogenetics or FISH.
Microarray based CGH has proven to be specific, sensi-
tive, and rapid for whole genome analysis in a single
experiment [40,41] and without cell culture [13]. Micro-
arrays also provide distinct advantages over conventional
and molecular cytogenetics (pre and post natal, cancer
and oncology) analysis because they have the potential to
detect the majority of microscopic and sub microscopic
chromosomes changes from any DNA sources with or
without whole genome amplification [42,43].
Other advantage of array-CGH is the increase in resolu-
tion that can be achieved compared to chromosome-
based CGH. For BAC arrays, the limit of resolution is on
the order of 100–200 kb with full genome coverage using
a minimal tiling path of overlapping clones. Constitu-
tional deletions as small as 40 kb have been detected
using an array encompassing a 7 Mb interval of chromo-
some 22 with 90% coverage [44]. A-CGH can also provide
a technically less demanding and more sensitive assay
than classic CGH or even routine cytogenetics. This is
because it is more amenable to automation and provides
finer resolution and better quality controls. Thus, it
appears likely that in the next few years, array based CGH
will become routinely used in clinical cytogenetics
Conclusion
Our study confirms the importance of the combination of
different techniques like chromosome banding, FISH and
array-CGH to completely analyse the complex chromo-
somal rearrangements. FISH was essential in the confir-
Table 1: FISH results showing the presence of inversion and duplication of 9p22.1-9p24 region on the derivative chromosome 9.
FISH
FISH probes locus array-CGH normal 9 der(9)
PCP 9p 9p Gain 9p22.1-9p24 + ++ (inv/split)
PCP 9q 9q normal + ++ (inv/split)
Satellite I Centromere 9 non analyzed + +
Satellite III 9q heterochromatine non analyzed + ++ (inv/split)
9p telomere 9p24.3 normal + +
9q telomere 9q ter normal + +
RP11-149I2 9p21.3 non analyzed + + (inv)
RP11-109M15 9p22 gain + ++ (inv)
RP11-91E3 9p23 gain + ++ (inv)




Split: splitted FISH signalMolecular Cytogenetics 2008, 1:27 http://www.molecularcytogenetics.org/content/1/1/27
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mation of the cytogenetic abnormality and further
delineation of the chromosomal disorder. Array-based
CGH has much greater multiplexing capabilities than
FISH but our study shows the irreplaceable role of FISH
technology in molecular cytogenetic diagnostics. This de
novo complex chromosome rearrangement illustrates the
possible risk of chromosome or gene defects in ICSI pro-
gram and the contribution of array-CGH for mapping rap-
idly de novo chromosomal imbalance.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All the authors contributed to and have approved the final
version of the manuscript
Acknowledgements
The authors would like to thanks ONS shili for the technical support
References
1. Mau-Haulzmann U: Somatic chromosomal abnormalities in
infertile men and women.  Cytogenet Genome Res 2005, 111(3–
4):317-336.
2. Allen V, Wilson R, Cheung A: Pregnancy outcomes after
assisted reproductive technology.  J Obstet Gynaecol Can 2006,
28(3):220-250.
3. Gosden R, Trasler J, Lucifero D, Faddy M: Rare congenital disor-
ders, imprinted genes, and assisted reproductive technology.
Lancet 2003, 361:1975-7.
4. Littooij AS, Hochstenbach R, Sinke RJ, van Tintelen P, Giltay JC: Two
cases with partial trisomy 9p: molecular cytogenetic charac-
terization and clinical follow-up.  Am J Med Genet 2002,
109:125-32.
5. Hannam S, Greenough A, Dawson JM: An unusual presentation of
trisomy 9p syndrome with a partial Dandy-Walker malfor-
mation.  Eur J Pediatr 1999, 158:1012.
6. Hengstschlager M, Bettelheim D, Repa C, Lang S, Deutinger J, Ber-
naschek G: A fetus with trisomy 9p and trisomy 10p originat-
ing from unbalanced segregation of a maternal complex
chromosome rearrangement t(4;10;9).  Fetal Diagn Ther 2002,
17(4):243-6.
7. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C,
Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson
DG: High resolution analysis of DNA copy number variation
using comparative genomic hybridization to microarrays.
Nat Genet 1998, 20:207-11.
8. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A,
Dohner H, Cremer T, Lichter P: Matrix-based comparative
genomic hybridization: biochips to screen for genomic
imbalances.  Genes Chromosomes Cancer 1997, 20:399-407.
9. Veltman JA, Schoenmakers EF, Eussen BH, Janssen I, Merkx G, van
Cleef B, van Ravenswaaij CM, Brunner HG, Smeets D, van Kessel AG:
High-throughput analysis of subtelomeric chromosome
rearrangements by use of array-based comparative genomic
hybridization.  Am J Hum Genet 2002, 70:1269-1276.
10. Vissers L, De Vries BB, Osoegawa K, Janssen IM, Feuth T, Choy CO,
Straatman H, Vliet W van der, Huys EH, van Rijk A, Smeets D, van
Ravenswaaij-Arts CM, Knoers NV, Burgt I van der, de Jong PJ, Brun-
ner HG, van Kessel AG, Schoenmakers EF, Veltman JA: Array-based
comparative genomic hybridization for the genome wide
detection of submicroscopic chromosomal abnormalities.
Am J Hum Genet 2003, 73:1261-1270.
11. Schoumans J, Anderlid BM, Blennow E, Teh BT, Nordenskjold M: The
performance of CGH array for the detection of cryptic con-
stitutional chromosome imbalances.  J Med Genet 2004,
41:198-202.
12. Shaw-Smith C, Redon R, Rickman L, Rio M, Willatt L, Fiegler H, Firth
H, Sanlaville D, Winter R, Colleaux L, Bobrow M, Carter NP: Micro-
array based comparative genomic hybridisation (array-
CGH) detects submicroscopic chromosomal deletions and
duplications in patients with learning disability/mental retar-
dation and dysmorphic features.  J Med Genet 2004, 41:241-248.
13. Benkhalifa1 M, Kasakyan S, Clement P, Baldi M, Tachdjian G, Demirol
D, Gurgan T, Fiorentino F, Mohammed M, M Qumsiyeh MB: Array
comparative genomic hybridization profiling of first-trimes-
ter spontaneous abortions that fail to grow in vitro.  Prentat
Diagnosis 2005, 25:894-900.
14. Brisset S, Kasakyan S, Coulomb A, Mairovitz V, Gautier E, Aubry MC,
Benkhalifa M, Tachdjian G: De novo monosomy 9p24.3-pter and
trisomy 17q24.3-qter characterized by microarray CGH in a
fetus with an increased nuchal translucency.  Prenatal Diagnosis
2006, 26:206-213.
15. Shaffer L, Bejjani B: A cytogenetic perspective on genomic
microarray.  Hum reprod Update 10(3):221-226.
16. Shaffer L, Bejjani B: Medical application of array CGHand the
transformation ofclinical cytogenetics.  Cytogenet Genome Res
2006, 115(3–4):303-309.
17. Jozwiak E, Ulug U, Mesut A, Erden H, Bahceci M: Prenatal karyo-
types of fetuses c conceived by intracytoplasmic sperm injec-
tion.  Fetil Steril 2004, 82(3):628-33.
18. Philipp T, Feichtinger W, Van Allen M, Separovic E, Reiner A,
Kalousek D: Abnormal embryonic development diagnosed
embryoscopically in early intrauterine deaths after in vitro
fertilization: a preliminary report of 23 cases.  Fertil Steril 2004,
82(5):1337-1342.
19. Govaerts I, Englert Y, Vamos E, Rodesch F: Sex chromosome
abnormalities after intracytoplasmic sperm injection.  Lancet
1995, 346:773.
20. Bonduelle M, Liebaers I, Deketelaere V, et al.: Neonatal data on a
cohort of 2889 infants born after ICSI (1991–1999) and of
2995 infants born after IVF (1983–1999).  Hum Reprod 2002,
17:671-94.
21. Samli H, Solak M, Imirzalioglu N, Beyatli Y, Simsek S, Kahraman S:
Fetal chromosomal analysis of pregnancies following intrac-
ytoplasmic sperm injection with amniotic tissue culture.  Pre-
nat Diagn 2004, 24:579-80.
22. Goto T, Holding C, Daniels R, Salpekar A, Monk M: Gene expres-
sion studies on human primordial germ cells and preimplan-
tation embryos.  Ital J Anat Embryol 2001, 106:119-27.
23. Basaran S, Engur A, Aytan M, Karaman B, Ghanbari A, Toksoy G, Yuk-
sel A, Cancat D, Kervancioglu E, Wollnik B, Bahceci M, Yuksel-Apak
M: The results of cytogenetics analysis with regard to intrac-
ytoplasmic sperm injection in males, females and fetuses.
Fetal Diagn Ther 2004, 19:313-318.
24. Vanderstichele S, Savary JB, Dufour P, Berard J, Tordjeman N, Vina-
tier D, Monnier JC, de Martinville B: Prenatal diagnosis of partial
trisomy 9p.  J Gynecol Obstet Biol Reprod 1997, 26:630-2.
25. Baccichetti C, Lenzini E, Temperani P, Pallotta R, Giorgi PL, Tarantino
E, Mengarda G, Dordi B: Partial trisomy 9. Clinical and cytoge-
netic correlations.  Ann Génét 1979, 22:199-204.
26. Cuoco C, Gimelli G, Pasquali F, Poloni L, Zuffardi O, Alicata P, Batta-
glino G, Bernardi F, Cerone R, Cotellessa M, Ghidoni A, Motta S:
Duplication of the short arm of chromosome 9. Analysis of
five cases.  Hum Genet 1982, 61:3-7.
27. Kaosaar ME, Mikelsaar AV, Talvik TA, Mikelsaar RV: A case of tri-
somy for the short arm of chromosome 9(+9p).  Hum Genet
1976, 34:77-80.
28. Kushnick T, Adessa GM: Partial trisomy 9 with resemblance to
Coffin-Siris syndrome.  J Med Genet 1976, 13:237-9.
29. Canun S, Mutchinick O, Shaffer LG, Fernandez C: Combined tri-
somy 9 and Ullrich-Turner syndrome in a girl with a
46,X,der(9)t(X;9)(q12;q32) karyotype.  Am J Med Genet 1998,
16:199-203.
30. Chen CP, Chang TY, Shih JC, Lin SP, Lin CJ, Wang W, Lee CC, Town
DD, Pan CW, Tzen CY: Prenatal diagnosis of the Dandy-
Walker malformation and ventriculomegaly associated with
partial trisomy 9p and distal 12p deletion.  Prenat Diagn 2002,
22:1063-6.
31. Meschede D, Louwen F, Eiben B, Horst J: Intracytoplasmic sperm
injection pregnancy with fetal trisomy 9p resulting from a
balanced paternal translocation.  Hum Reprod 1997, 12:1913-4.
32. Teebi AS, Gibson L, McGrath J, Meyn MS, Breg WR, Yang-Feng TL:
Molecular and Cytogenetic Characterization of 9p-Abnor-
malities.  Am J Med Genet 1993, 46:288-292.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Molecular Cytogenetics 2008, 1:27 http://www.molecularcytogenetics.org/content/1/1/27
Page 10 of 10
(page number not for citation purposes)
33. Chen CP, Shih JC: Prenatal Diagnosis of Bilateral Ventriculom-
egaly and an Enlarged Cisterna Magna in a Fetus with Partial
Trisomy 9 and Partial Trisomy 21.  Prenat Diagn 1999,
19:1175-1180.
34. Haddad BR, Lin AE, Wyandt H, Milunsky A: Molecular cytogenetic
characterisation of the first familial case of partial 9p dupli-
cation (p22p24).  J Med Genet 1996, 33:1045-7.
35. Fujimoto A, Lin MS, Schwartz S: Direct duplication of 9p22 → p24
in a child with duplication 9p syndrome.  Am J Med Genet 1998,
77:268-71.
36. Bonaglia MC, Giorda R, Carrozzo R, Roncoroni ME, Grasso R, Bor-
gatti R, Zuffardi O: 20-Mb duplication of chromosome 9p in a
girl with minimal physical findings and normal IQ: narrowing
of the 9p duplication critical region to 6 Mb.  Am J Med Genet
2002, 112:154-9.
37. Carvalho B, Ouwerkek E, Meijer G, YIstra B: High resolution
microarray comparative genomic hybridisation analysis
using spotted oligonucleotides.  J Clin Pathol 2004,
57(6):644-646.
38. YIstra B, Ijssel P Van den, Carvalho B, Brakenhoff R, Meijer G: BAC
to the future or oligonucleotides: a perspective for micro
array comparative genomic hybridization (array CGH).
Nucleic Acids Res 2006, 34(2):445-450.
39. Rickman L, Fiegler H, Carter N, Bobrow M: Prenatal diagnosis by
array-CGH.  Eur J Med Genet 2005, 48(3):232-240.
40. Oostlander A, Meijer G, YIstra B: Microarray-based comparative
genomic hybridization and it's application in human genet-
ics.  Clin Genet 2004, 66(6):488-495.
41. Rickman L, Fiegler H, Carter N, Bobrow M: Prenatal diagnosis by
array-CGH.  Eur J Med Genet 2005, 48(3):232-240.
42. Knijnenburg J, burg M Van der, Nilsson P, Ploos van Amstel H, Tanke
H, Szuhai K: Rapid detection of genomic imbalances using
micro-arrays consisting of pooled BACs covering all human
chromosomes arms.  Nucleics Acid Re 2005, 12(33):e159.
43. Bejjani B, Shaffer L: Application of array-base comparative
genomic hybridization to clinical diagnostics.  J Mol Diagn 2006,
8(5):528-533.
44. Bruder C, Hivela C, Papia Paez I, Fransson I, Segraves r, Hamilton G,
Zhang X, Evans D, Wallace A, Baser M, Zucman-Rossi J, Hergersberg
M, Boltshauser E, Papi L, Rouleau G, Poptodorov G, Jordanova A,
Rask-Andersen H, Kluwe L, Mautner V, Sainio M, Hung G, Mathiesen
T, Moller C, Pulst S, Harder H, Heiberg A, Honda M, Nimura M,
Sahlen S, Blennow E, Albertson D, Pinkel D, Dumanski J: Height res-
olution deletion analysis of constitutional DNA from neurofi-
bromatosis type 2 ( NF2) patient using microarrays-CGH.
Hum Mol Genet 2001, 10(3):271-282.